Cytodyn's Covid result release is very good. It appears there is disappointment that there isn't immediate approval. There may yet be fast approval, however, irregardless the results disclosed so far meet their endpoints. www.otcmarkets.com/.../CytoDyn-Announces-Clinically-Significant-Top-line-Results-from-its-Phase-2-Trial-in-Mild-to-Moderate-COVID-19-Patients Anyhow, the data is going to the FDA. Despite the market's apparent confusion, this is clinically positive news.

For those browsing for updates: www.ncbi.nlm.nih.gov/pmc/articles/PMC7356106/ The Wall Street Journal wrote a correction the short article they posted for false misleading information. Yet another short report that hurt Cytodyn. investorshangout.com/.../view

What is needed in the US immediately is not a vaccine but drugs that make Covid infections not fatal. There are some treatments on the way to do that. GILD, CYDY, SRNE, ABBV, PTC, and AMPE are companies that have been to the FDA for rapid approval. Hopefully, they can get these through approval rapidly and conduct whatever else is needed to expand usage if applicable. Remdesivir's usage is only good for critical cases and is not effective on all of those, although it is better than none. At least it got fast tracked (some say it was from someone interfering with the FDA's trials). Regardless, hopefully they will get approval for others with better results.

If Covid ceases to be deadly if treated early then the urgency drops significantly. If it becomes a bad case of the flu that would be optimal. The government should fund this with greater urgency and money than questionable vaccines that drug companies want billions for without any results. I feel they want vaccines because they know the review process takes years (maybe a year) with questionable hopes for one to succeed if the drug companies submit candidates they even think have a hope to work. The longer it takes and more failures the better for their bottom line (if you want to be cynical).

The good issue about drugs that help remedy existing patients is it can be studied now, help existing patients. And can be verified faster than a vaccine. I figure that's why there are fewer of these such drug candidates.

LOL with delaying the outcome. If his term ends with no replacement, the next in succession is the Speaker of the House. Nancy Pelosi becomes the Interim President. The Constitution doesn't allow the current President to stay in office past his tenure.

I'm more concerned about the destruction of our Constitution when the President issues executive orders that purposely misallocates money from Congress, strips States of their money and their rights, and undermines the legislature. The Senate and the House are the only ones who have the right to allocate the money by Constitutional authority, Moreover, not collecting taxes as passed by the Congress is refusing to follow the law of the land and is a dereliction of executive duty. I would tend to say, America First when opposing this executive order as it attempts to destroy America by undermining the Constitution. Either this President is too stupid to know what this does, or is purposefully trying to undermine the Constitution. Both of which are more important to the economy or the crisis which was manufactured by having the Senate not deal with it until the last moment.

FYI this is an article published some time ago but shows information on the shorts and their behavior. I think this guy is well known by all.

Shorts may get crushed on further news as published Adam Feuerstein has reversed his take on CYDY's HIV prospects saying their HIV test may get approved. Also CYDY may release something soon, potentialy this week, as I stated before.

Here's an article on the sort's misleading claims about Cytodyn.

emerginggrowth.com/bio-path-nasdaq-bpth-cytodyn-otcqb-cydy-fact-checking-short-sided-analysis/

I think this has more to do with large caps getting somewhat overbought due to lower earnings is all. There is a decrease in production due to Corona, but there is an even greater decrease in supply and with stimulus weakening if not going away due to the fact that Presidents aren't legislative and can't spend on their own under the Constitution. There is some value plays in the tamped down other segments, but not much given market uncertainty.

I think this is more an issue with the supply of money looking for a place that has potential to deliver returns or appreciate which is hard in this market environment. Likewise, the move to bigger companies makes sense given they are eating the lunch of the rest of the economy as they have been for years and are thus doing pretty well for themselves. This is a persistent theme in the US economy for decades.